Artificial Intelligence

Facing global division and regulatory threats, 15 tech titans from AWS to Microsoft have formed a "Trusted Tech Alliance." But can it deliver on its promise?

A new partnership signals a major shift in the art market, placing scientific conservation at the heart of determining an asset's long-term value.

Emmy-winner Brandon McMillan will unveil a revolutionary new line of dog training tools at the pet industry's premier event. What does he have in store?

Toronto's Xanadu unveils a breakthrough quantum algorithm for chemistry while preparing for a major public listing via a $500 million SPAC deal.

Industry heavyweight Rick Seehausen takes the helm at Lenders One, a strategic move by Altisource to arm independent lenders for a shifting market.

A new "smart bomb" cancer drug, PB-223, shows complete tumor eradication with minimal toxicity in preclinical studies, setting the stage for a new battle.

With Jamie Tischart as CTO, OpenMetal aims to capture enterprises fleeing hyperscale clouds for open-source private infrastructure.

A new free tool tells you the exact year AI will take your job. We investigate if it's a wake-up call or a new form of digital fear-mongering.

South Easton's HUB Technical Services lands on CRN's prestigious Elite 150 list, recognized for its security-first approach to AI transformation.

A new ETF, EXEQ, uses AI to score and invest in corporate leadership, aiming to turn a qualitative trait into a data-driven source of returns.

With a $15 million funding boost, Nasus Pharma is accelerating its powder-based intranasal epinephrine, NS002, challenging the EpiPen's dominance.

Meltwater is now an Official Reddit Data Partner, unlocking a goldmine of unfiltered consumer insights. What does this mean for brands and data privacy?

A new report reveals America's youngest workers face a crisis of confidence while the much-hyped AI revolution stalls in the workplace.

The firm reports a $195M cash reserve but a wider net loss as it nears crucial data readouts for its novel depression and anxiety drug candidates.

Alto Neuroscience completes enrollment for a trial of its skin patch drug, ALTO-101, offering new hope for the millions battling cognitive decline in schizophrenia.

A new software upgrade uses AI to make low-cost drones perform like high-end systems, a breakthrough with major implications for defense and industry.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

Applied Optoelectronics breaks ground on a massive Texas facility, aiming to secure the domestic supply chain for the critical components powering America's AI boom.

New integration promises to slash response times by unifying leads in one inbox. Here’s why it’s a game-changer for local businesses and customer acquisition.